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What are trefoil peptides and what do they do?
Three members of the mammalian trefoil peptide family are currently known: trefoil factor 1 (TFF1 formerly pS2) is expressed by surface and pit epithelial cells of both the fundic (body) and especially the antral (distal) stomach; trefoil factor 2 (TFF2 formerly spasmolytic polypeptide or SP) is produced by antral gland and fundic mucus neck as well as Brunners gland cells; trefoil factor 3 (TFF3 formerly intestinal trefoil factor or ITF) is a product of intestinal and colonic goblet cells and is expressed in intestinal metaplasia of the esophagus and stomach. A common feature of these peptides is that their synthesis is closely associated with that of gastrointestinal mucus (TFF1 and MUC5AC; TFF2 and MUC6; TFF3 and MUC2), and that their genes are clustered together on chromosome 21q22.3 in humans. All are synthesized ectopically throughout the gut in response to chronic inflammatory or acute ulcerative damage. Their common documented functions in normal gastric homeostasis include inhibition of apoptosis, promotion of cell migration in response to day-to-day injury, inhibition of inflammation, and augmentation of the barrier function of mucus (22, 23) , although the mechanism by which the latter is accomplished physiologically is unknown. Only the homeostatic stomach-expressed trefoils TFF1 and 2 will be reviewed here.
Gastric trefoil peptides are also likely to play a critical role in disease processes including chronic inflammation, ulceration and in cancer progression (18) . TFF1 is secreted from surface/pit mucus cells of the stomach, the cell type with which H. pylori most closely associates. Tff1 gene expression is strongly inhibited in about 50% of distal cancers of the Page 3 of 21 4 human stomach (18, 23) , and this observation coupled with the discrete phenotype of tff1 null mice, which develop antral tumours and subsequently adenocarcinomas, suggests that this trefoil functions as a stomach-specific tumor suppressor gene (23) . Support for this idea comes from numerous studies including: (i) an investigation of a large series of human gastric tumors which show reduced TFF1 expression, loss of heterozygosity, and numerous somatic mutations particularly in the region encoding the trefoil motif and which is essential for biological activity (17) ; (ii) the observation that TFF1, given exogenously or when the gene is transfected, effectively inhibits cancer cell proliferation by delaying G 1 -S phase transition (23); (iii) the biological activity of trefoil factor loop 1 proteins, engineered to express known human mutations, which lose growth inhibitory ability and show enhanced cell invasion (25) ; (iv) the observation that depletion of TFF1 inhibits epithelial cell maturation pathways resulting in an accumulation of undifferentiated cells and endoplasmic reticulum stress (23) , both of which may promote the initiation of carcinogenesis.
Under normal conditions, TFF1 is secreted apically into the overlying mucus layer (and subsequently into gastric juice), where it interacts with mucins and promotes repair after mucosal damage. Although classical receptors have not been identified for any of the trefoil peptides, 2 hybrid studies have shown a specific association between TFF1 and the vonWillebrand c-domains (vWD-c) of Muc 5AC (23), the main secreted mucin of stomach surface and pit epithelial cells. However the functional mechanism for this association is not well understood. This is important because mucins are generally accepted as being integral in protecting the underlying epithelium from acid and 
Reciprocal regulation of trefoil peptide expression by cytokines
We previously showed that TFF2 is expressed not only by gastrointestinal epithelial mucus cells, but also by several lymphoid organs including the spleen, lymph nodes and thymus, and is upregulated by the bacterial antigen lipopolysaccharide (reviewed in 2). 
IL-6 family cytokine signaling
The cytokines of the IL-6 family, including IL-6, IL-11, IL-27, leukemia inhibitory factor, oncostatin M, ciliary neurotrophic factor, cardiotropin-like related cytokine, and cardiotropin-1, all commonly utilise the trans-membrane receptor glycoprotein gp130 for signal transduction. IL-6 and IL-11 are the most prevalent and physiologically relevant family cytokines expressed in the gastrointestinal tract. These cytokines initiate signaling by binding their specific receptors (IL-6R and IL-11R respectively) which in turn Page 6 of 21 associate with, and lead to recruitment and homodimerization of the common signal transducing receptor subunit gp130, ultimately resulting in the activation of the JAK/STAT and SHP-2/ras/MAPK/ERK1-2/AP-1 signaling cascades (9, 14) , which under normal conditions are in homeostatic balance (Fig. 1A) . In vitro studies using recombinant cytokines and cancer cell lineages or primary cultures have illustrated that gp130 signals in numerous organ systems including the gut, and regulates diverse biological functions. In these tissues, gp130 signaling has been found to play roles in the regulation of cell differentiation, proliferation, survival, as well as hormone secretion and inflammatory responses (9, 14) . where it has specific tumour suppressor activity, and that IL-6 family cytokines are particularly important determinants of TFF1 synthesis.
Which IL-6 family cytokines regulate gastric mucosal pathology?
IL-6 is generally considered to be a pro-inflammatory cytokine, the expression of which is associated with H. pylori-induced inflammation, and several stomach and colon- Surprisingly, in the absence of IL-6, gastric tumour growth occurred with the same incidence, and at the same age of onset and rate, as in gp130 FF mice. In addition STAT3
activation was undiminished and correlated with tumour progression. Significantly, we found that although IL-6 appeared to be dispensable for tumour development, in its absence the incidence and extent of submucosal invasion, the first step in tumour metastasis, was increased 10 fold. This suggests that a cytokine signalling through gp130
other than IL-6 is responsible for tumour progression, and further that IL-6, at least in this (A) Balanced IL-6 family cytokine signalling via SHP2/ras/Erk and STAT3 leads to gastric mucosal homeostasis.
(B) Mutation of tyrosine 757 on the intracellular arm of mouse gp130, results in the loss of IL-6 family cytokine-mediated SHP2/ras/Erk/AP-1 regulation of the tumor suppressor gene tff1, and hyperactivation of STAT3 after loss of negative regulation by SHP-2 and SOCS3.
